Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BDSX vs $NRC | Chartloom

Compare

$BDSX vs $NRC

Biodesix Inc · National Research Corp

BDSX

Biodesix Inc

NRC

National Research Corp

Compare $BDSX vs $NRC

Comparing Biodesix Inc and National Research Corp

BDSXBiodesix Inc

NRCNational Research Corp

BDSXBiodesix Inc

Market cap

$249M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.00x

Rev growth (TTM)

34.5%

YTD performance

271.4%

52W performance

224.2%

FCF yield

-8.2%

NRCNational Research Corp

Market cap

$452M

P/E (TTM)

81.00x

Forward P/E (NTM)

21.29x

Forward P/S (NTM)

3.04x

Rev growth (TTM)

-0.2%

YTD performance

13.3%

52W performance

78.0%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BDSX

NRC

Detailed metrics comparison

BDSX

Biodesix Inc

NRC

National Research Corp

Market Cap

BDSX$249M

NRC$452M

Enterprise Value

BDSX$265M

NRC$539M

Price

BDSX$23.99

NRC$20.43

P/E Ratio

BDSXN/A

NRC81.00x

P/S Ratio

BDSX2.41x

NRC3.23x

EV/Sales

BDSX2.58x

NRC3.85x

EV/EBITDA

BDSX0.00x

NRC23.06x

P/B Ratio

BDSX30.02x

NRC68.67x

P/FCF Ratio

BDSXN/A

NRC20.90x

EV/FCF

BDSX-13.01x

NRC24.91x

PEG Ratio

BDSXN/A

NRCN/A

Forward P/E (NTM)

BDSXN/A

NRC21.29x

Forward P/S (NTM)

BDSX2.00x

NRC3.04x

Revenue (TTM)

BDSX$103M

NRC$140M

Revenue Growth (YoY)

BDSX34.5%

NRC-0.2%

Forward Rev Growth

BDSX20.2%

NRC8.3%

Gross Margin (TTM)

BDSX82.5%

NRC61.7%

Operating Margin (TTM)

BDSX0.0%

NRC10.5%

EBITDA Margin (TTM)

BDSX-14.6%

NRC16.7%

Net Margin (TTM)

BDSX-27.0%

NRC4.0%

FCF Margin (TTM)

BDSX-19.8%

NRC15.5%

Net Income (TTM)

BDSX$-28M

NRC$6M

FCF (TTM)

BDSX$-20M

NRC$22M

EPS (TTM)

BDSX-$2.70

NRC$0.25

ROE (TTM)

BDSX-16487.0%

NRC48.5%

ROA (TTM)

BDSX-3033.0%

NRC4.3%

ROIC (TTM)

BDSX-2700.0%

NRC6.2%

Cash

BDSX$30M

NRC$3M

Debt

BDSX$47M

NRC$90M

Net Cash/Debt

BDSX$-17M

NRC$-87M

Current Ratio (TTM)

BDSX2.85x

NRC0.65x

Quick Ratio (TTM)

BDSX2.85x

NRC0.50x

Debt/Equity (TTM)

BDSX5.12x

NRC13.75x

Debt/Assets (TTM)

BDSX0.0%

NRC0.0%

Interest Coverage (TTM)

BDSXN/A

NRCN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

NRC0.00x

Beta

BDSX0.60

NRC0.26

52W Performance

BDSX224.2%

NRC78.0%

YTD Performance

BDSX271.4%

NRC13.3%

% from 52W High

BDSX-25.0%

NRC-13.7%

% from 52W Low

BDSX356.1%

NRC85.5%

Asset Turnover (TTM)

BDSX1.12x

NRC1.03x

FCF Yield (TTM)

BDSX-8.2%

NRC4.8%

Earnings Yield (TTM)

BDSX-11.2%

NRC1.2%

Dividend Yield (TTM)

BDSXN/A

NRC2.8%

Rule of 40

BDSX14.6

NRC15.2

EV/GP/RG

BDSX0.15

NRC0.98

Ticker research

View BDSX research View NRC research

Metric	BDSX Biodesix Inc	NRC National Research Corp
Market & Valuation
Market Cap	$249M	$452M
Enterprise Value	$265M	$539M
Price	$23.99	$20.43
P/E Ratio	N/A	81.00x
P/S Ratio	2.41x	3.23x
EV/Sales	2.58x	3.85x
EV/EBITDA	0.00x	23.06x
P/B Ratio	30.02x	68.67x
P/FCF Ratio	N/A	20.90x
EV/FCF	-13.01x	24.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.29x
Forward P/S (NTM)	2.00x	3.04x
Revenue & Growth
Revenue (TTM)	$103M	$140M
Revenue Growth (YoY)	34.5%	-0.2%
Forward Rev Growth	20.2%	8.3%
Profitability
Gross Margin (TTM)	82.5%	61.7%
Operating Margin (TTM)	0.0%	10.5%
EBITDA Margin (TTM)	-14.6%	16.7%
Net Margin (TTM)	-27.0%	4.0%
FCF Margin (TTM)	-19.8%	15.5%
Net Income (TTM)	$-28M	$6M
FCF (TTM)	$-20M	$22M
EPS (TTM)	-$2.70	$0.25
ROE (TTM)	-16487.0%	48.5%
ROA (TTM)	-3033.0%	4.3%
ROIC (TTM)	-2700.0%	6.2%
Financial Health
Cash	$30M	$3M
Debt	$47M	$90M
Net Cash/Debt	$-17M	$-87M
Current Ratio (TTM)	2.85x	0.65x
Quick Ratio (TTM)	2.85x	0.50x
Debt/Equity (TTM)	5.12x	13.75x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.26
52W Performance	224.2%	78.0%
YTD Performance	271.4%	13.3%
% from 52W High	-25.0%	-13.7%
% from 52W Low	356.1%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.03x
FCF Yield (TTM)	-8.2%	4.8%
Earnings Yield (TTM)	-11.2%	1.2%
Dividend Yield (TTM)	N/A	2.8%
Other
Rule of 40	14.6	15.2
EV/GP/RG	0.15	0.98
Ticker research	View BDSX research	View NRC research

Valuation

P/E Ratio

NRC

81.00x

P/S Ratio

BDSX

2.41x

NRC

3.23x

EV/FCF

BDSX

-13.01x

NRC

24.91x

Growth & revenue

Revenue Growth TTM

BDSX

34.5%

NRC

-0.2%

Forward Revenue Growth

BDSX

20.2%

NRC

8.3%

Profitability & performance

Gross Margin

BDSX

82.5%

NRC

61.7%

ROE

NRC

48.5%

BDSX

-16487.0%

FCF Yield %

NRC

4.8%

BDSX

-8.2%

52-Week Performance

BDSX

224.2%

NRC

78.0%

Detailed metrics comparison

BDSX

Biodesix Inc

NRC

National Research Corp

Market Cap

BDSX$249M

NRC$452M

Enterprise Value

BDSX$265M

NRC$539M

Price

BDSX$23.99

NRC$20.43

P/E Ratio

BDSXN/A

NRC81.00x

P/S Ratio

BDSX2.41x

NRC3.23x

EV/Sales

BDSX2.58x

NRC3.85x

EV/EBITDA

BDSX0.00x

NRC23.06x

P/B Ratio

BDSX30.02x

NRC68.67x

P/FCF Ratio

BDSXN/A

NRC20.90x

EV/FCF

BDSX-13.01x

NRC24.91x

PEG Ratio

BDSXN/A

NRCN/A

Forward P/E (NTM)

BDSXN/A

NRC21.29x

Forward P/S (NTM)

BDSX2.00x

NRC3.04x

Revenue (TTM)

BDSX$103M

NRC$140M

Revenue Growth (YoY)

BDSX34.5%

NRC-0.2%

Forward Rev Growth

BDSX20.2%

NRC8.3%

Gross Margin (TTM)

BDSX82.5%

NRC61.7%

Operating Margin (TTM)

BDSX0.0%

NRC10.5%

EBITDA Margin (TTM)

BDSX-14.6%

NRC16.7%

Net Margin (TTM)

BDSX-27.0%

NRC4.0%

FCF Margin (TTM)

BDSX-19.8%

NRC15.5%

Net Income (TTM)

BDSX$-28M

NRC$6M

FCF (TTM)

BDSX$-20M

NRC$22M

EPS (TTM)

BDSX-$2.70

NRC$0.25

ROE (TTM)

BDSX-16487.0%

NRC48.5%

ROA (TTM)

BDSX-3033.0%

NRC4.3%

ROIC (TTM)

BDSX-2700.0%

NRC6.2%

Cash

BDSX$30M

NRC$3M

Debt

BDSX$47M

NRC$90M

Net Cash/Debt

BDSX$-17M

NRC$-87M

Current Ratio (TTM)

BDSX2.85x

NRC0.65x

Quick Ratio (TTM)

BDSX2.85x

NRC0.50x

Debt/Equity (TTM)

BDSX5.12x

NRC13.75x

Debt/Assets (TTM)

BDSX0.0%

NRC0.0%

Interest Coverage (TTM)

BDSXN/A

NRCN/A

Net Debt/EBITDA (TTM)

BDSX0.00x

NRC0.00x

Beta

BDSX0.60

NRC0.26

52W Performance

BDSX224.2%

NRC78.0%

YTD Performance

BDSX271.4%

NRC13.3%

% from 52W High

BDSX-25.0%

NRC-13.7%

% from 52W Low

BDSX356.1%

NRC85.5%

Asset Turnover (TTM)

BDSX1.12x

NRC1.03x

FCF Yield (TTM)

BDSX-8.2%

NRC4.8%

Earnings Yield (TTM)

BDSX-11.2%

NRC1.2%

Dividend Yield (TTM)

BDSXN/A

NRC2.8%

Rule of 40

BDSX14.6

NRC15.2

EV/GP/RG

BDSX0.15

NRC0.98

Ticker research

View BDSX research View NRC research

Metric	BDSX Biodesix Inc	NRC National Research Corp
Market & Valuation
Market Cap	$249M	$452M
Enterprise Value	$265M	$539M
Price	$23.99	$20.43
P/E Ratio	N/A	81.00x
P/S Ratio	2.41x	3.23x
EV/Sales	2.58x	3.85x
EV/EBITDA	0.00x	23.06x
P/B Ratio	30.02x	68.67x
P/FCF Ratio	N/A	20.90x
EV/FCF	-13.01x	24.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	21.29x
Forward P/S (NTM)	2.00x	3.04x
Revenue & Growth
Revenue (TTM)	$103M	$140M
Revenue Growth (YoY)	34.5%	-0.2%
Forward Rev Growth	20.2%	8.3%
Profitability
Gross Margin (TTM)	82.5%	61.7%
Operating Margin (TTM)	0.0%	10.5%
EBITDA Margin (TTM)	-14.6%	16.7%
Net Margin (TTM)	-27.0%	4.0%
FCF Margin (TTM)	-19.8%	15.5%
Net Income (TTM)	$-28M	$6M
FCF (TTM)	$-20M	$22M
EPS (TTM)	-$2.70	$0.25
ROE (TTM)	-16487.0%	48.5%
ROA (TTM)	-3033.0%	4.3%
ROIC (TTM)	-2700.0%	6.2%
Financial Health
Cash	$30M	$3M
Debt	$47M	$90M
Net Cash/Debt	$-17M	$-87M
Current Ratio (TTM)	2.85x	0.65x
Quick Ratio (TTM)	2.85x	0.50x
Debt/Equity (TTM)	5.12x	13.75x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.60	0.26
52W Performance	224.2%	78.0%
YTD Performance	271.4%	13.3%
% from 52W High	-25.0%	-13.7%
% from 52W Low	356.1%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	1.12x	1.03x
FCF Yield (TTM)	-8.2%	4.8%
Earnings Yield (TTM)	-11.2%	1.2%
Dividend Yield (TTM)	N/A	2.8%
Other
Rule of 40	14.6	15.2
EV/GP/RG	0.15	0.98
Ticker research	View BDSX research	View NRC research